High Flow Nasal Cannula Market Size, Trends and Insights By Product Type (Single Heated Tube, Nasal Cannula, Active Humidifier, Air Blender), By Application (Acute Respiratory Failure, Chronic Obstructive Pulmonary Disease, Acute Heart Failure, Others), By End User (Hospitals and Clinics, Ambulatory Care Centers, Long-term Care Centers, Others), By Sales Channel (Direct Channel, Indirect Channel), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 – 2034
Report Snapshot
| Study Period: | 2025-2034 |
| Fastest Growing Market: | North America |
| Largest Market: | Asia Pacific |
Major Players
- Vapotherm Inc.
- Armstrong Medical Ltd
- Salter Labs Inc
- ResMed Inc.
- Others
Reports Description
As per the current market research conducted by the CMI Team, the Global High Flow Nasal Cannula Market is expected to record a CAGR of 5.4% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 3.7 billion. By 2034, the valuation is anticipated to reach USD 5.9 billion.
High Flow Nasal Cannula Market Overview
A medical device called a High Flow nasal cannula is used to enable High Flow therapy, also referred to as heated humidified High Flow therapy. Patients with respiratory disorders can receive a steady supply of medicinal gas through the cannula, which is a component of a respiratory support system.
The primary function of the High Flow nasal cannula is to facilitate the delivery of 100% oxygen and 60 liters of medicinal gas per minute. The conventional medical gas delivery system, the nasal cannula, which can provide 1-6 liters of medical gas per minute, has been partially replaced by the High Flow nasal cannula.
The medical requirements of patients with severe or life-threatening respiratory disorders can be satisfied because the apparatus supports high flow. Patients with respiratory obstruction or failure brought on by illnesses including bronchiolitis, acute exacerbations of chronic obstructive pulmonary disease (COPD), congestive heart failure, asthma, pneumonia, and a few others are usually treated with it. Due to the growing number of patients worldwide, the High Flow nasal cannula business is expanding quickly.
- As per the study by JAMA Network, it is estimated that the number of COPD cases globally among those aged 25 years and older will increase by 23% from 2020 to 2050, approaching 600 million patients with COPD globally by 2050.
High Flow Nasal Cannula Market Growth Factors
Growing prevalence of smoking drives market growth
One of the reasons behind the market for high-flow nasal cannulas (HFNCs) expanding dramatically is the rising frequency of smoking. Smoking is among the main risk factors for disorders like chronic obstructive pulmonary disease (COPD) and asthma. Like smoking raises the frequency of these respiratory diseases, the use of effective respiratory support devices like HFNC systems is absolutely essential.
The Global Action to End Smoking research estimates that 253.0 million Indians aged 15 and above will use tobacco products in 2022 (200.2 million men and 53.5 million women). For the total number of tobacco users, this ranks second globally and first in the WHO South-East Asia Region.
Increasing collaboration is expected to florish the industry expansion
The growing collaboration is expected to offer a lucrative opportunity for market growth during the forecast period. For instance, in March 2023, The Desert Oasis Healthcare (DOHC) system in California has adopted a respiratory patient monitoring program that uses data from Teva’s Digihaler System, according to a statement released by Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.
The program was created in partnership with Rimidi, a top clinical management platform that aims to improve patient experiences, streamline clinical workflows, and meet quality standards. The first and only intelligent inhaler device that can give objective data to aid patients and their physicians in better supporting asthma control is Teva’s Digihaler.
High Flow Nasal Cannula Market Challenge
High cost of equipment and subsequent treatment
A High Flow nasal cannula is expensive. The cost of a standard High Flow nasal cannula, for example, typically begins at USD 2000 and may increase depending on its features and other characteristics. Furthermore, according to a National Institutes of Health (NIH) study, the average cost of using a High Flow nasal cannula per patient in the United States was around USD 368.
Additionally, the total cost of therapy is significantly higher because it includes additional related charges like hospital stays, insurance, complementary therapies, and other extraneous expenses. The high cost of equipment and treatment in general is anticipated to limit the growth of the High Flow nasal cannula sector.
High Flow Nasal Cannula Market Segmentation Analysis
By Product Type:
The single heated tube segment is expected to dominate the market. To guarantee that the oxygen being given is both warmed and humidified, single heated tubes are essential to HFNC systems. By avoiding airway dryness and preserving mucosal integrity, this procedure greatly increases patient comfort and improves therapeutic results.
Besides, the nasal cannula segment is growing at a rapid rate. The market is driven by technological advancements, increasing prevalence of respiratory diseases, and expanding applications across various healthcare settings.
By Application:
The acute respiratory failure segment is expected to dominate the market. As a non-invasive substitute for traditional oxygen therapy and non-invasive ventilation, the High Flow nasal cannula is used as an initial support approach for ARF and post-extubation. Thus, driving the market growth.
On the other hand, the chronic obstructive pulmonary disease segment is expected to grow at the fastest rate over the forecast period due to the rising cases of COPD. Moreover, the increasing advancements in the devices florish the market growth.
Report Scope
| Feature of the Report | Details |
| Market Size in 2025 | USD 3.7 Billion |
| Projected Market Size in 2034 | USD 5.9 Billion |
| Market Size in 2024 | USD 3.5 Billion |
| CAGR Growth Rate | 5.4% CAGR |
| Base Year | 2024 |
| Forecast Period | 2025-2034 |
| Key Segment | By Product Type, Application, End User, Sales Channel and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
High Flow Nasal Cannula Market Regional Analysis
North America is projected to dominate the high flow nasal cannula market. This is because of the region’s growing disease prevalence, developed infrastructure, and the strong presence of important players. In addition, a few additional factors driving market expansion in North America include expanding air pollution, an aging population, and an increasing need for fast-acting and highly effective medications.
However, the Asia Pacific is projected to capture the significant market share in 2024. This is due to the rising prevalence of smoking. Moreover, the shift towards home healthcare drives the industry expansion.
High Flow Nasal Cannula Market Recent Development
The high-flow nasal cannula industry adopted several strategies, which include product launches, acquisitions, collaboration, expansion, and others. Some of the company strategies include
- In July 2024, Deeptech company Cosmian announced a major technological breakthrough with the deployment of its encryption technology for Gmail. This integration marks a strategic milestone for the company as it continues its mission to deploy client-side encryption for the most widely used business applications. With its Key Management System (KMS), Cosmian now addresses the protection of messages exchanged on Gmail, which naturally constitute a reservoir of extremely sensitive data. With Cosmian, it is now possible to encrypt emails on Gmail very simply without altering the user experience.
- In January 2023, AstraZeneca’s Tezspire (tezepelumab) received CHMP’s positive opinion for self-administration in a prefilled pen for severe asthma in patients aged 12 years & older, offering increased flexibility and convenience.
The increasing collaboration and product launch are the strategies that have expanded the market presence of the company in the high-flow nasal cannula industry and gained its competitive edge.
List of the prominent players in the High Flow Nasal Cannula Market:
- Vapotherm Inc.
- Armstrong Medical Ltd
- Salter Labs Inc
- ResMed Inc.
- Teleflex Inc
- BD
- Smiths Medical
- Flexicare Medical Ltd
- Teijin Pharma Limited
- TNI Medical AG
- Fisher & Paykel Healthcare Limited
- Hamilton Medical AG
- Drägerwerk AG & Co. KGaA
- Heka Medicals India Pvt Ltd.
- GaleMed Corporation
- Others
The High Flow Nasal Cannula Market is segmented as follows:
By Product Type
- Single Heated Tube
- Nasal Cannula
- Active Humidifier
- Air Blender
By Application
- Acute Respiratory Failure
- Chronic Obstructive Pulmonary Disease
- Acute Heart Failure
- Others
By End User
- Hospitals and Clinics
- Ambulatory Care Centers
- Long-term Care Centers
- Others
By Sales Channel
- Direct Channel
- Indirect Channel
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global High Flow Nasal Cannula Market, (2025-2034) (USD Billion)
- 2.2 Global High Flow Nasal Cannula Market : snapshot
- Chapter 3. Global High Flow Nasal Cannula Market – Industry Analysis
- 3.1 High Flow Nasal Cannula Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rapid technological advancements
- 3.2.2 Rising prevalence of COPD
- 3.2.3 The use of tobacco is on the rise.
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porters Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Product Type
- 3.7.2 Market attractiveness analysis By Application
- 3.7.3 Market attractiveness analysis By End User
- 3.7.4 Market attractiveness analysis By Sales Channel
- Chapter 4. Global High Flow Nasal Cannula Market-—Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global High Flow Nasal Cannula Market: company market share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global High Flow Nasal Cannula Market – Product Type Analysis
- 5.1 Global High-Flow Nasal Cannula Market Overview: By Product Type
- 5.1.1 Global High Flow Nasal Cannula Market share, By Product Type, 2024 and 2034
- 5.2 Single Heated Tube
- 5.2.1 Global High Flow Nasal Cannula Market by Single Heated Tube, 2025-2034 (USD Billion)
- 5.3 Nasal Cannula
- 5.3.1 Global High Flow Nasal Cannula Market by Nasal Cannula, 2025-2034 (USD Billion)
- 5.4 Active Humidifier
- 5.4.1 Global High Flow Nasal Cannula Market by Active Humidifier, 2025-2034 (USD Billion)
- 5.5 Air Blender
- 5.5.1 Global High Flow Nasal Cannula Market by Air Blender, 2025-2034 (USD Billion)
- 5.1 Global High-Flow Nasal Cannula Market Overview: By Product Type
- Chapter 6. Global High Flow Nasal Cannula Market – Application Analysis
- 6.1 Global High Flow Nasal Cannula Market overview: By Application
- 6.1.1 Global High Flow Nasal Cannula Market share, By Application, 2024 and 2034
- 6.2 Acute Respiratory Failure
- 6.2.1 Global High Flow Nasal Cannula Market by Acute Respiratory Failure, 2025-2034 (USD Billion)
- 6.3 Chronic Obstructive Pulmonary Disease
- 6.3.1 Global High Flow Nasal Cannula Market by Chronic Obstructive Pulmonary Disease, 2025-2034 (USD Billion)
- 6.4 Acute Heart Failure
- 6.4.1 Global High Flow Nasal Cannula Market by Acute Heart Failure, 2025-2034 (USD Billion)
- 6.5 Others
- 6.5.1 Global High Flow Nasal Cannula Market by Others, 2025-2034 (USD Billion)
- 6.1 Global High Flow Nasal Cannula Market overview: By Application
- Chapter 7. Global High Flow Nasal Cannula Market End-User Analysis
- 7.1 Global High Flow Nasal Cannula Market overview: By End User
- 7.1.1 Global High Flow Nasal Cannula Market share, By End User, 2024 and 2034
- 7.2 Hospitals and Clinics
- 7.2.1 Global High Flow Nasal Cannula Market by Hospitals and Clinics, 2025-2034 (USD Billion)
- 7.3 Ambulatory Care Centers
- 7.3.1 Global High Flow Nasal Cannula Market by Ambulatory Care Centers, 2025-2034 (USD Billion)
- 7.4 Long-term Care Centers
- 7.4.1 Global High Flow Nasal Cannula Market by Long-term Care Centers, 2025-2034 (USD Billion)
- 7.5 Others
- 7.5.1 Global High Flow Nasal Cannula Market by Others, 2025-2034 (USD Billion)
- 7.1 Global High Flow Nasal Cannula Market overview: By End User
- Chapter 8. Global High Flow Nasal Cannula Market – Sales Channel Analysis
- 8.1 Global High Flow Nasal Cannula Market overview: By Sales Channel
- 8.1.1 Global High Flow Nasal Cannula Market share, By Sales Channel, 2024 and 2034
- 8.2 Direct Channel
- 8.2.1 Global High Flow Nasal Cannula Market by Direct Channel, 2025-2034 (USD Billion)
- 8.3 Indirect Channel
- 8.3.1 Global High Flow Nasal Cannula Market by Indirect Channel, 2025-2034 (USD Billion)
- 8.1 Global High Flow Nasal Cannula Market overview: By Sales Channel
- Chapter 9. High Flow Nasal Cannulas Market – Regional Analysis
- 9.1 Global High Flow Nasal Cannulas Market Regional Overview
- 9.2 Global High Flow Nasal Cannulas Market Share, by Region, 2024 & 2034 (USD Billion)
- 9.3. North America
- 9.3.1 North America High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.3.1.1 North America High Flow Nasal Cannulas Market, by Country, 2025-2034 (USD Billion)
- 9.3.1 North America High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.4 North America High Flow Nasal Cannulas Market, by Product Type, 2025-2034
- 9.4.1 North America High Flow Nasal Cannulas Market, by Product Type, 2025-2034 (USD Billion)
- 9.5 North America High Flow Nasal Cannulas Market, by Application, 2025-2034
- 9.5.1 North America High Flow Nasal Cannulas Market, by Application, 2025-2034 (USD Billion)
- 9.6 North America High Flow Nasal Cannulas Market, by End User, 2025-2034
- 9.6.1 North America High Flow Nasal Cannulas Market, by End User, 2025-2034 (USD Billion)
- 9.7 North America High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034
- 9.7.1 North America High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034 (USD Billion)
- 9.8. Europe
- 9.8.1 Europe High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.8.1.1 Europe High Flow Nasal Cannulas Market, by Country, 2025-2034 (USD Billion)
- 9.8.1 Europe High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.9 Europe High Flow Nasal Cannulas Market, by Product Type, 2025-2034
- 9.9.1 Europe High Flow Nasal Cannulas Market, by Product Type, 2025-2034 (USD Billion)
- 9.10 Europe High Flow Nasal Cannulas Market, by Application, 2025-2034
- 9.10.1 Europe High Flow Nasal Cannulas Market, by Application, 2025-2034 (USD Billion)
- 9.11 Europe High Flow Nasal Cannulas Market, by End User, 2025-2034
- 9.11.1 Europe High Flow Nasal Cannulas Market, by End User, 2025-2034 (USD Billion)
- 9.12 Europe High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034
- 9.12.1 Europe High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034 (USD Billion)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.13.1.1 Asia Pacific High Flow Nasal Cannulas Market, by Country, 2025-2034 (USD Billion)
- 9.13.1 Asia Pacific High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.14 Asia Pacific High Flow Nasal Cannulas Market, by Product Type, 2025-2034
- 9.14.1 Asia Pacific High Flow Nasal Cannulas Market, by Product Type, 2025-2034 (USD Billion)
- 9.15 Asia Pacific High Flow Nasal Cannulas Market, by Application, 2025-2034
- 9.15.1 Asia Pacific High Flow Nasal Cannulas Market, by Application, 2025-2034 (USD Billion)
- 9.16 Asia Pacific High Flow Nasal Cannulas Market, by End User, 2025-2034
- 9.16.1 Asia Pacific High Flow Nasal Cannulas Market, by End User, 2025-2034 (USD Billion)
- 9.17 Asia Pacific High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034
- 9.17.1 Asia Pacific High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034 (USD Billion)
- 9.18. Latin America
- 9.18.1 Latin America High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.18.1.1 Latin America High Flow Nasal Cannulas Market, by Country, 2025-2034 (USD Billion)
- 9.18.1 Latin America High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.19 Latin America High Flow Nasal Cannulas Market, by Product Type, 2025-2034
- 9.19.1 Latin America High Flow Nasal Cannulas Market, by Product Type, 2025-2034 (USD Billion)
- 9.20 Latin America High Flow Nasal Cannulas Market, by Application, 2025-2034
- 9.20.1 Latin America High Flow Nasal Cannulas Market, by Application, 2025-2034 (USD Billion)
- 9.21 Latin America High Flow Nasal Cannulas Market, by End User, 2025-2034
- 9.21.1 Latin America High Flow Nasal Cannulas Market, by End User, 2025-2034 (USD Billion)
- 9.22 Latin America High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034
- 9.22.1 Latin America High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034 (USD Billion)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.23.1.1 The Middle-East and Africa High Flow Nasal Cannulas Market, by Country, 2025-2034 (USD Billion)
- 9.23.1 The Middle-East and Africa High Flow Nasal Cannulas Market, 2025-2034 (USD Billion)
- 9.24 The Middle-East and Africa High Flow Nasal Cannulas Market, by Product Type, 2025-2034
- 9.24.1 The Middle-East and Africa High Flow Nasal Cannulas Market, by Product Type, 2025-2034 (USD Billion)
- 9.25 The Middle-East and Africa High Flow Nasal Cannulas Market, by Application, 2025-2034
- 9.25.1 The Middle-East and Africa High Flow Nasal Cannulas Market, by Application, 2025-2034 (USD Billion)
- 9.26 The Middle-East and Africa High Flow Nasal Cannulas Market, by End User, 2025-2034
- 9.26.1 The Middle-East and Africa High Flow Nasal Cannulas Market, by End User, 2025-2034 (USD Billion)
- 9.27 The Middle-East and Africa High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034
- 9.27.1 The Middle-East and Africa High Flow Nasal Cannulas Market, by Sales Channel, 2025-2034 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Vapotherm Inc.
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Armstrong Medical Ltd
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Salter Labs Inc
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 ResMed Inc.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 Teleflex Inc
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 BD
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 Smiths Medical
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Flexicare Medical Ltd
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Teijin Pharma Limited
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 TNI Medical AG
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Fisher & Paykel Healthcare Limited
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Hamilton Medical AG
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Drägerwerk AG & Co. KGaA
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 Heka Medicals India Pvt Ltd.
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 GaleMed Corporation
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Others.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.1 Vapotherm Inc.
List Of Figures
Figures No 1 to 32
List Of Tables
Tables No 1 to 102
Prominent Player
- Vapotherm Inc.
- Armstrong Medical Ltd
- Salter Labs Inc
- ResMed Inc.
- Teleflex Inc
- BD
- Smiths Medical
- Flexicare Medical Ltd
- Teijin Pharma Limited
- TNI Medical AG
- Fisher & Paykel Healthcare Limited
- Hamilton Medical AG
- Drägerwerk AG & Co. KGaA
- Heka Medicals India Pvt Ltd.
- GaleMed Corporation
- Others
FAQs
The High Flow Nasal Cannula market is driven by several factor such as rapid technological advancements, rising prevalence of COPD, rising tobacco use and many others.
The “Acute Respiratory Failure” had the largest share in the global market for High Flow Nasal Cannula.
The “Single Heated Tube” category dominated the market in 2024.
The key players in the market are Vapotherm Inc., Armstrong Medical Ltd, Salter Labs Inc, ResMed Inc., Teleflex Inc, BD, Smiths Medical, Flexicare Medical Ltd, Teijin Pharma Limited, TNI Medical AG, Fisher & Paykel Healthcare Limited, Hamilton Medical AG, Drägerwerk AG & Co. KGaA, Heka Medicals India Pvt Ltd., GaleMed Corporation, Others.
“North America” is expected to dominate the market over the forecast period.
The global market is projected to grow at a CAGR of 5.4% during the forecast period, 2025-2034.
The High Flow Nasal Cannula Market size was valued at USD 3.7 Billion in 2025.